CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-13 | Ballal Rahul D. Director | Option exercise | +3,388 | 5,690 | ||
| 2024-06-13 | Ballal Rahul D. Director | Option exercise · Restricted stock units | −3,388 | 0 | ||
| 2024-06-13 | Smith Cynthia Director | Option exercise | +3,388 | 5,690 | ||
| 2024-06-13 | Smith Cynthia Director | Option exercise · Restricted stock units | −3,388 | 0 | ||
| 2024-06-13 | Ho Maykin Director | Option exercise | +3,388 | 14,912 | ||
| 2024-06-13 | Ho Maykin Director | Option exercise · Restricted stock units | −3,388 | 0 | ||
| 2024-06-13 | Scadden David Director | Option exercise | +3,388 | 15,483 | ||
| 2024-06-13 | Scadden David Director | Option exercise · Restricted stock units | −3,388 | 0 | ||
| 2024-06-13 | Owen Catherine E. Director | Option exercise | +1,976 | 1,976 | ||
| 2024-06-13 | Owen Catherine E. Director | Option exercise · Restricted stock units | −1,976 | 3,953 | ||
| 2024-06-13 | CAPELLO JEFFREY D Director | Option exercise | +1,976 | 1,976 | ||
| 2024-06-13 | CAPELLO JEFFREY D Director | Option exercise · Restricted stock units | −1,976 | 3,953 | ||
| 2024-06-05 | Goff Brian Chief Executive Officer | Option exercise 10b5-1 | +25,527 | 79,307 | ||
| 2024-06-05 | Goff Brian Chief Executive Officer | Sale 10b5-1 | −12,115 | $48.84 | $592K | 67,192 |
| 2024-06-05 | Goff Brian Chief Executive Officer | Option exercise · Performance share units 10b5-1 | −25,527 | 76,583 | ||
| 2024-06-03 | Washburn Theodore James Jr. Principal Accounting Officer | Sale | −1,362 | $44.39 | $60K | 1,524 |
| 2024-04-10 | FOUSE JACQUALYN A Director | Sale 10b5-1 | −7,791 | $27.55 | $215K | 137,396 |
| 2024-04-08 | FOUSE JACQUALYN A Director | Option exercise 10b5-1 | +15,934 | 145,187 | ||
| 2024-04-08 | FOUSE JACQUALYN A Director | Option exercise · Restricted stock units 10b5-1 | −15,934 | 15,933 | ||
| 2024-03-07 | Foster-Cheek Kaye I Director | Sale | −1,285 | $31.62 | $41K | 5,524 |
Page 21 of 48 · 941 trades